ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Blood Test Discussion
Lab Results - Defy consult, what to expect?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Vince" data-source="post: 36910" data-attributes="member: 843"><p>ApoE Genotype and Coronary Artery DiseaseAngiographic studies of CHD patients have shown that apo E4 carriers are more often found to have disseminated and severe coronary lesions than noncarriers.[SUP]<a href="http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19#footnote-13" target="_blank">13</a>[/SUP] The apoE genotype is reported to increase an individual carrier's differential susceptibility to future coronary artery disease (CAD) events. In larger studies and pooled analyses, apo E4 is associated with increased CAD events compared to apo E2 and apo E3. Reported CAD event risk is increased about 40% in apo E4 individuals.[SUP]<a href="http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19#footnote-32" target="_blank">32</a>[/SUP]</p><p>A meta-analysis of clinical events in 6,355 individuals in nine observational studies </p><p></p><p><a href="http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19" target="_blank">http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19</a></p></blockquote><p></p>
[QUOTE="Vince, post: 36910, member: 843"] ApoE Genotype and Coronary Artery DiseaseAngiographic studies of CHD patients have shown that apo E4 carriers are more often found to have disseminated and severe coronary lesions than noncarriers.[SUP][URL="http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19#footnote-13"]13[/URL][/SUP] The apoE genotype is reported to increase an individual carrier's differential susceptibility to future coronary artery disease (CAD) events. In larger studies and pooled analyses, apo E4 is associated with increased CAD events compared to apo E2 and apo E3. Reported CAD event risk is increased about 40% in apo E4 individuals.[SUP][URL="http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19#footnote-32"]32[/URL][/SUP] A meta-analysis of clinical events in 6,355 individuals in nine observational studies [URL]http://www.bhlinc.com/clinicians/clinical-references/reference-manual/chapter19[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Blood Test Discussion
Lab Results - Defy consult, what to expect?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top